Ituran Location and Control Ltd. - Ordinary Shares (ITRN)
37.12
+0.43 (1.17%)
NASDAQ · Last Trade: Aug 22nd, 6:57 PM EDT
Via Benzinga · August 19, 2025
Ituran (ITRN) posted record Q2 2025 revenue of $86.8M but missed analyst EPS and revenue estimates, causing its stock to decline.
Via Chartmill · August 19, 2025

Founded in 1994, Ituran Location and Control Ltd. (ITRN) is an Israeli company that specializes in telematics services and machine-to-machine telematics products.
Via Talk Markets · February 6, 2025

Via Benzinga · November 20, 2024

Via Benzinga · June 3, 2025

These stocks have an unusual volume in today's session
Via Chartmill · February 24, 2025

Ituran Location and Control Ltd (ITRN) is a provider of location-based services. Ituran’s share price rose about 36.27% in the past year from $25.84 to $34.85 as of Monday’s market close.
Via Talk Markets · February 12, 2025
Ituran Location and Control is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products.
Via Talk Markets · January 9, 2025

Ituran Location and Control Ltd is a provider of location-based services. Ituran’s share price rose 17.5% in the past year from $24.87 to $29.22 as of Monday’s market close.
Via Talk Markets · November 25, 2024

ITRN stock results show that Ituran Location & Control beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 19, 2024

ITRN stock results show that Ituran Location & Control beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 28, 2024

While innovators are known for eschewing dividends, these tech stocks for growth and income prove you can enjoy both.
Via InvestorPlace · May 1, 2024

Discover stocks for early retirement dreams and their potential in electronic components, semiconductors and communications equipment.
Via InvestorPlace · April 10, 2024

Via Benzinga · March 14, 2024

Although passive income leaders tend to be boring enterprises, these dividend tech stocks would like to change the narrative.
Via InvestorPlace · March 7, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Via Benzinga · March 11, 2024